Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence

Stonesifer, C. J., Djavid, A. R., Grimes, J. M., Khaleel, A. E., Soliman, Y. S., Maisel-Campbell, A., Garcia-Saleem, T. J., Geskin, L. J., & Carvajal, R. D. (2021). Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.734354
Authors:
Connor J Stonesifer
A Reza Djavid
Joseph M Grimes
Alexandra E Khaleel
Yssra S Soliman
Amanda Maisel-Campbell
Tiffany J Garcia-Saleem
Larisa J Geskin
Richard D Carvajal
Affiliated Authors:
Connor J Stonesifer
A Reza Djavid
Joseph M Grimes
Alexandra E Khaleel
Yssra S Soliman
Amanda Maisel-Campbell
Tiffany J Garcia-Saleem
Larisa J Geskin
Richard D Carvajal
Author Keywords:
basal cell carcimoma (bcc)
immune checkpoint inhibition (ici)
immunotherapy
merkel cell carcinoma (mcc)
non-melanoma skin cancer (nmsc)
squamous cell carcinoma (scc)
Publication Type:
Article
Unique ID:
10.3389/fonc.2021.734354
PMID:
Publication Date:
Data Source:
PubMed

Record Created: